Generic Name and Formulations:
Benzphetamine HCl 50mg; scored tabs.
Various generic manufacturers
Indications for Benzphetamine:
Short-term adjunct in management of exogenous obesity.
Initially 25–50mg daily in mid-morning or mid-afternoon. Increase if needed to 25–50mg 1–3 times daily.
Advanced arteriosclerosis. Cardiovascular disease. Hypertension. Hyperthyroidism. Agitation. Drug or alcohol abuse. During or within 14 days of MAOIs. Pregnancy (Cat.X).
Discontinue after a few weeks as tolerance to anorectic effect occurs. Diabetes. Prescribe limited supply to prevent overdose. Nursing mothers: not recommended.
Hypertensive crisis with MAOIs. Blocks guanethidine. Altered insulin requirements. Potentiated by urinary alkalinizers. Antagonized by urinary acidifiers.
Abuse potential, impairment in hazardous activities, arrhythmias, hypertension, CNS overstimulation, psychosis, dry mouth, GI disturbances, urticaria, impotence.
Formerly known under the brand name Didrex.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Lithium Monotherapy Effective in Treating Bipolar Disorder in Children
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Cognitive Behavioral Therapy May Alter Suicidal Ideation in Anxiety Disorders
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses
- Autism Spectrum Disorders Associated With Depression in Young Adults
- Gestational Diabetes Associated With Increased Risk for Postpartum Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Smartphone-Based Psychoeducational Programs May Be Effective for Bipolar Disorder Management